363 related articles for article (PubMed ID: 10048010)
1. [Diffuse malignant melanoma of the uvea. A clinico-histopathologic study of 39 patients].
Braun UC; Rummelt VC; Naumann GO
Klin Monbl Augenheilkd; 1998 Dec; 213(6):331-40. PubMed ID: 10048010
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
3. Eye-wall resection.
Char DH; Miller T; Crawford JB
Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
[TBL] [Abstract][Full Text] [Related]
5. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
6. Uveal and conjunctival malignant melanoma in denmark 1943-97: observed and relative survival of patients followed through 2002.
Isager P; Engholm G; Overgaard J; Storm H
Ophthalmic Epidemiol; 2006 Apr; 13(2):85-96. PubMed ID: 16581612
[TBL] [Abstract][Full Text] [Related]
7. ["Biocytology" of diffuse malignant melanomas of the anterior uvea (preliminary report)].
Henke V; Naumann GO
Klin Monbl Augenheilkd; 1988 Apr; 192(4):289-95. PubMed ID: 3404939
[TBL] [Abstract][Full Text] [Related]
8. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
Coupland SE; Campbell I; Damato B
Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
[TBL] [Abstract][Full Text] [Related]
9. [The staging of malignant uveal melanoma].
Cernea P; Ispas G; Mihai I
Oftalmologia; 1992; 36(3):229-38. PubMed ID: 1520679
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic study of malignant melanoma of the uvea treated by enucleation].
Bacin F; Kantelip B; Albuisson E; Bonhomme R
J Fr Ophtalmol; 1988; 11(10):639-49. PubMed ID: 3072363
[TBL] [Abstract][Full Text] [Related]
11. Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern.
Lindegaard J; Isager P; Prause JU; Heegaard S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3268-75. PubMed ID: 16877391
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
13. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance.
Kivelä T; Eskelin S; Mäkitie T; Summanen P
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2085-93. PubMed ID: 11481276
[TBL] [Abstract][Full Text] [Related]
14. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
Heindl LM; Hofmann TN; Knorr HL; Rummelt C; Schrödl F; Schlötzer-Schrehardt U; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Invest Ophthalmol Vis Sci; 2009 May; 50(5):1988-95. PubMed ID: 19151383
[TBL] [Abstract][Full Text] [Related]
15. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
17. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy.
Summanen P; Immonen I; Heikkonen J; Tommila P; Laatikainen L; Tarkkanen A
Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359
[TBL] [Abstract][Full Text] [Related]
19. Local environmental influences on uveal melanoma: vitreous humor promotes uveal melanoma invasion, whereas the aqueous can be inhibitory.
Canovas D; Rennie IG; Nichols CE; Sisley K
Cancer; 2008 Apr; 112(8):1787-94. PubMed ID: 18300240
[TBL] [Abstract][Full Text] [Related]
20. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma.
Schmittel A; Bechrakis NE; Martus P; Mutlu D; Scheibenbogen C; Bornfeld N; Foerster MH; Thiel E; Keilholz U
Eur J Cancer; 2004 Nov; 40(16):2389-95. PubMed ID: 15519510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
